Search Results - "Trilianos, Panagiotis"

The Reliability of Fibro-test in Staging Orthotopic Liver Transplant Recipients with Recurrent Hepatitis C by Trilianos, Panagiotis, Tsangaris, Adamantios, Tawadros, Augustine, Deshpande, Vrushak, Pyrsopoulos, Nikolaos

“…Liver biopsy remains the gold standard for staging of chronic liver disease following orthotopic liver transplantation. Noninvasive assessment of fibrosis with…”
Get full text

Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience by Malik, Mohammad U, Ucbilek, Enver, Trilianos, Panagiotis, Cameron, Andrew M, Gurakar, Ahmet

“…Hepatitis B core antibody immunoglobulin G seropositivity is evidence of past exposure to hepatitis B virus. Donor or recipient hepatitis B core antibody…”
Get full text

Greater Biosynthetic Liver Dysfunction in Primary Sclerosing Cholangitis Suggests Co-existent or Impending Cholangiocarcinoma by Trilianos, Panagiotis, Agnihotri, Abhishek, Ucbilek, Enver, Gurakar, Ahmet

“…Background and Aim : Patients with primary sclerosing cholangitis (PSC) who develop cholangiocarcinoma (CCA) have a median survival of less than 6 months. In…”
Get full text

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit by Vafiadis, Irene, Trilianos, Panagiotis, Vlachogiannakos, Jiannis, Karagiorga, Markisia, Hatziliami, Antonia, Voskaridou, Ersi, Ladas, Spiros D

“…HCV infection and transfusional iron overload in Thalassemic patients may result in liver disease. HCV treatment in Thalassemia has raised safety concerns…”
Get full text

The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data by Pyrsopoulos, Nikolaos, Trilianos, Panagiotis, Lingiah, Vivek A, Fung, Phoenix, Punnoose, Merlin

“…BACKGROUNDRecurrent hepatitis C (RHC) in orthotopic liver transplantation (OLT) population is associated with accelerated rates of fibrosis, low efficacy and…”
Get full text

Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis by Trilianos, Panagiotis, Selaru, Florin, Li, Zhiping, Gurakar, Ahmet

“…Cholangiocarcinoma (CCA) is the most common hepatobiliary malignancy complicating primary sclerosing cholangitis (PSC). Unfortunately, timely diagnosis of CCA…”
Get more information

Mo1057 Higher Degree of Biochemical Liver Dysfunction At Diagnosis of Primary Sclerosing Cholangitis May Be Associated With Impending or Concurrent Cholangiocarcinoma by Trilianos, Panagiotis, Limketkai, Berkeley N, Chen, Po-Hung, Agnihotri, Abhishek, Gurakar, Ahmet

Get full text

The predictors of post-transplant coronary events among liver transplant recipients by Malik, Mohammad U., Russell, Stuart D., Pustavoitau, Aliaksei, Chacko, Matthews, Cosar, Arif M., Thompson, Carol B., Trilianos, Panagiotis, Dagher, Nabil N., Cameron, Andrew M., Gurakar, Ahmet

“…Background/purpose Cardiac morbidities can occur during the peri- and post-liver transplant (LT) period, affecting the long-term survival. The purpose of this…”
Get full text

Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation by Chen, Po-Hung, Limketkai, Berkeley N., Trilianos, Panagiotis, Pirtini-Cetingul, Muge, Woreta, Tinsay A., Kim, Brian, Gulsen, Murat T., Segev, Dorry L., Cameron, Andrew M., Gurakar, Ahmet

“…Objective To characterize the risk of liver‐related events and death in hepatitis B virus (HBV)‐exposed liver transplantation (LT) recipients. Methods…”
Get full text